Oncolytic virus and inhibitor for NEDD8-activating enzyme pevonedistat: Promising combination for cancer therapy?

Mol Ther. 2023 Nov 1;31(11):3112-3114. doi: 10.1016/j.ymthe.2023.10.008. Epub 2023 Oct 20.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Antineoplastic Agents* / pharmacology
  • Cyclopentanes / pharmacology
  • Cyclopentanes / therapeutic use
  • Enzyme Inhibitors
  • Humans
  • NEDD8 Protein
  • Neoplasms* / drug therapy
  • Oncolytic Viruses* / genetics

Substances

  • pevonedistat
  • Antineoplastic Agents
  • Cyclopentanes
  • Enzyme Inhibitors
  • NEDD8 protein, human
  • NEDD8 Protein